Strategic Acquisition The recent acquisition of CHEORS by PharmAlliance presents an opportunity for cross-selling advanced HEOR and market-access solutions to a broader client base within the pharmaceutical and life sciences sectors, potentially expanding revenue streams.

Sustainability Focus CHEORS emphasizes a holistic approach to health economic insights and supports value-based contracts, indicating a strong alignment with growing industry trends toward sustainability and value-driven healthcare, which could appeal to payers and pharma companies seeking innovative cost management solutions.

Technology Utilization Utilizing modern tech stacks such as WordPress, MySQL, and animation tools, CHEORS demonstrates a commitment to efficient digital service delivery, providing opportunities to upsell advanced data analytics, visualization, and software integrations to existing clients.

Market Expansion With capabilities in economic modeling, HTA submissions, and systematic reviews, CHEORS is well-positioned to target expanding global markets, particularly in regions emphasizing health technology assessments, offering potential for new regional business development.

Financial Opportunity Generating revenue between $10M and $25M with a lean team size, CHEORS offers scalable partnership opportunities through targeted outreach in HEOR services, especially by leveraging its niche expertise to secure new contracts with biotech firms and payers seeking sophisticated economic assessment solutions.